A Dose-Regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects with Advanced Malignancies
Description: 

To determine the maximum tolerated dose (MTD) of Oraxol in subjects with advanced malignancies.

Study Number: 

PH 242613

Phase: 
I
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01967043

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.